Spine Align Raises $1.75M Series Seed Round

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

September 14, 2020

Spine Align, LLC, a medical device company developing a portfolio of products that enable spine surgeons to measure, visualize, and adjust patients’ spinal alignment during surgery, recently closed a $1.75M Series Seed round.

Spine Align reports the financing is led by the Rockies Venture Club, with additional support by members of the Berkeley Angel Network, NO/LA Angel Network, Pasadena Angels, Bellingham Angels, the Abell Foundation, and VentureWell. This round supports development efforts to achieve FDA 510(k) clearance for their flagship product, LiveAlignTM, in 2021.

“This milestone is a culmination of years of tireless work by our team to build an innovative platform of products that rethink what’s possible for spine surgeons today. We could not be more grateful to our investor partners, medical and business advisory board members, and engineering team to bring us to where we are today and where we are heading,” said Amir Soltanianzadeh, CEO & Co-Founder.

“The solution that Spine Align has developed will have a dramatic impact on spinal surgery. Rockies Venture Club was proud to lead this funding round and found that many investors across the country saw the same potential in the company,” added Dave Harris, Director of Operations at Rockies Venture Club.

“This funding round represents a tremendous milestone of being closer to positively impacting the lives of patients with our technology. LiveAlignTM is just the first of many products in our portfolio that will seamlessly augment the art of surgery with digital feedback,” said Dr. David Gullotti, CTO & Co-Founder.

“The Spine Align platform leverages the infrastructure of image-guided and robotic technologies to deliver the next generation of surgery. My colleagues and I cannot wait to use this breakthrough technology in the operating room next year,” said Dr. Nicholas Theodore, Co-Founder of Spine Align and Director of the Neurological Spine Program at the Johns Hopkins Hospital.



Related Articles